Efficacy and safety of a 0/1-h high-sensitivity cardiac troponin I (hs-cTnI) protocol to rule out acute coronary syndrome over a one-year period

Kelly Perryman , David Winchester , Michael Massoomi , Elizabeth Warren , Linda Morris , Stacy Beal , Nila Radhakrishnan , Umar Ghaffar , Jacob Sammon , Justin Raman , Marsha Lewis , David Crabb , Liam Holtzman , Brandon Allen

Vessel Plus ›› 2023, Vol. 7 ›› Issue (1) : 7

PDF
Vessel Plus ›› 2023, Vol. 7 ›› Issue (1) :7 DOI: 10.20517/2574-1209.2022.34
Original Article

Efficacy and safety of a 0/1-h high-sensitivity cardiac troponin I (hs-cTnI) protocol to rule out acute coronary syndrome over a one-year period

Author information +
History +
PDF

Abstract

Aim: Evaluate the diagnostic and prognostic performance of the ESC 0/1H Algorithm and its utility in safely discharging patients with suspected Acute Coronary Syndrome (ACS) in the Emergency Department.

Methods: This analysis is a retrospective cohort study of 3,156 patients presenting to an academic medical center emergency department (ED) between May 20, 2019 and May 31, 2020. After completing the Beckman Coulter Access High Sensitivity Troponin I (hs-TnI) assay per current institution protocol (T0, T1H, T3H), patients identified to have symptoms concerning ACS were retrospectively analyzed using the ESC 0/1H Algorithm to assess the safety and efficacy of a rule-out algorithm for early discharge.

Results: The negative predictive value (NPV) of the protocol (T0 < 6 pg/mL; or females with T0 ≤ 15 pg/mL and T1 ≤ 15 pg/mL; or males with T0 ≤ 20 pg/mL and T1 ≤ 20 pg/mL) was 99.4% (95%CI: 99.0-99.7%) for acute myocardial injury at the initial ED visit (index ED visit) and/or 30-day cardiac-related death. The negative likelihood ratio was 0.08 (95%CI: 0.05%-0.13%), and the specificity was 86.3% (95%CI: 85.0-87.5%).

Conclusion: The protocol was found to have a NPV greater than 99% and a negative likelihood ratio of 0.08, suggesting it is safe to use for patients presenting to the ED with ACS symptoms no matter the time of symptom onset.

Keywords

High sensitivity troponin / emergency medicine / myocardial infarction

Cite this article

Download citation ▾
Kelly Perryman, David Winchester, Michael Massoomi, Elizabeth Warren, Linda Morris, Stacy Beal, Nila Radhakrishnan, Umar Ghaffar, Jacob Sammon, Justin Raman, Marsha Lewis, David Crabb, Liam Holtzman, Brandon Allen. Efficacy and safety of a 0/1-h high-sensitivity cardiac troponin I (hs-cTnI) protocol to rule out acute coronary syndrome over a one-year period. Vessel Plus, 2023, 7(1): 7 DOI:10.20517/2574-1209.2022.34

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Benjamin EJ,Chiuve SE.Heart disease and stroke statistics-2017 update: a report from the american heart association.Circulation2017;135:e146-603

[2]

Virani SS,Aparicio HJ.Heart disease and stroke statistics-2021 update: a report from the american heart association.Circulation2021;143:e254-743

[3]

Boeddinghaus J,Nestelberger T.Clinical validation of a novel high-sensitivity cardiac troponin I assay for early diagnosis of acute myocardial infarction.Clin Chem2018;64:1347-60

[4]

Amsterdam EA,Brindis RG.2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Circulation2014;130:e344-426

[5]

Thygesen K,Jaffe AS.Fourth universal definition of myocardial infarction.J Am Coll Cardiol2018;72:2231-64

[6]

Tan JWC,Kasim SS.Asia-Pacific consensus statement on the optimal use of high-sensitivity troponin assays in acute coronary syndromes diagnosis: focus on hs-TnI.Heart Asia2017;9:81-7 PMCID:PMC5388929

[7]

Nowak RM,Jacobsen G.Performance of novel high-sensitivity cardiac troponin i assays for 0/1-hour and 0/2- to 3-hour evaluations for acute myocardial infarction: results from the HIGH-US study.Ann Emerg Med2020;76:1-13

[8]

Thygesen K,Giannitsis E.How to use high-sensitivity cardiac troponins in acute cardiac care.Eur Heart J2012;33:2252-7

[9]

Koechlin L,Nestelberger T.Performance of the ESC 0/2h-algorithm using high-sensitivity cardiac troponin I in the early diagnosis of myocardial infarction.Am Heart J2021;242:132-7

[10]

Boeddinghaus J,Cullen L.Two-hour algorithm for triage toward rule-out and rule-in of acute myocardial infarction by use of high-sensitivity cardiac troponin I.Clin Chem2016;62:494-504

[11]

Collet JP,Barbato E.2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.Eur Heart J2021;42:1289-367

[12]

Twerenbold R,Sörensen NA.Prospective validation of the 0/1-h algorithm for early diagnosis of myocardial infarction.J Am Coll Cardiol2018;72:620-32

[13]

Boeddinghaus J,Koechlin L.Early diagnosis of myocardial infarction with point-of-care high-sensitivity cardiac troponin I.J Am Coll Cardiol2020;75:1111-24

[14]

Boeddinghaus J,Nestelberger T.Clinical use of a new high-sensitivity cardiac troponin I assay in patients with suspected myocardial infarction.Clin Chem2019;65:1426-36

[15]

Boeddinghaus J,Twerenbold R.High-sensitivity cardiac troponin I assay for early diagnosis of acute myocardial infarction.Clin Chem2019;65:893-904

[16]

Cook B,Hudson M.Baseline high sensitivity cardiac troponin I level below limit of quantitation rules out acute myocardial infarction in the emergency department.Crit Pathw Cardiol2021;20:4-9 PMCID:PMC7899745

[17]

Kontos MC.High-sensitivity troponins in cardiovascular disease.Curr Cardiol Rep2020;22:30

[18]

Allen BR,Cohen SA.Diagnostic performance of high-sensitivity cardiac troponin T strategies and clinical variables in a multisite US cohort.Circulation2021;143:1659-72

[19]

Chapman AR,Boeddinghaus J.Comparison of the efficacy and safety of early rule-out pathways for acute myocardial infarction.Circulation2017;135:1586-96 PMCID:PMC5404406

[20]

Morrow DA.Clinician’s guide to early rule-out strategies with high-sensitivity cardiac troponin.Circulation2017;135:1612-6

[21]

Januzzi JL Jr.Evaluating chest pain in the emergency department: searching for the optimal gatekeeper.J Am Coll Cardiol2018;71:617-9

[22]

Shortt C,Whitlock R.Economic considerations of early rule-in/rule-out algorithms for the diagnosis of myocardial infarction in the emergency department using cardiac troponin and glycemic biomarkers.Clin Chem2017;63:593-602

[23]

Anand A,Chapman AR.High-sensitivity cardiac troponin on presentation to rule out myocardial infarction: a stepped-wedge cluster randomized controlled trial.Circulation2021;143:2214-24 PMCID:PMC8177493

[24]

Jülicher P,Parsonage WA.The organisational value of diagnostic strategies using high-sensitivity troponin for patients with possible acute coronary syndromes: a trial-based cost-effectiveness analysis.BMJ Open2017;7:e013653 PMCID:PMC5577894

[25]

Ambavane A,Giannitsis E.Economic evaluation of the one-hour rule-out and rule-in algorithm for acute myocardial infarction using the high-sensitivity cardiac troponin T assay in the emergency department.PLoS One2017;12:e0187662

[26]

Stoyanov KM,Biener M.RAPID-CPU: a prospective study on implementation of the ESC 0/1-hour algorithm and safety of discharge after rule-out of myocardial infarction.Eur Heart J Acute Cardiovasc Care2020;9:39-51 PMCID:PMC7008552

[27]

High-sensitivity* cardiac troponin I and T assay analytical characteristics designated by manufacturer IFCC committee on clinical applications of cardiac bio-markers (C-CB) V062019. Available from: https://ifcc.org/ifcc-education-division/emd-committees/committee-on-clinical-applications-of-cardiac-bio-markers-c-cb/biomarkers-reference-tables/ [Last accessed on 24 March 2023]

[28]

CDRH. 510(k) substantial equivalence determination decision memorandum assay only template. Available from: https://www.accessdata.fda.gov/cdrh_docs/reviews/K170200.pdf [Last accessed on 24 March 2023]

[29]

Wu AHB,Greene DN.Clinical laboratory practice recommendations for the use of cardiac troponin in acute coronary syndrome: expert opinion from the academy of the American association for clinical chemistry and the task force on clinical applications of cardiac bio-markers of the international federation of clinical chemistry and laboratory medicine.Clin Chem2018;64:645-55

[30]

Beal SG,Wilkerson G,Allen B.Comparison of patient results on a new high-sensitivity troponin I assay with a conventional assay, focusing on clinically relevant cutpoints.J Appl Lab Med2020;5:597-9

[31]

Chiang CH,Pickering JW.Performance of the European society of cardiology 0/1-hour, 0/2-hour, and 0/3-hour algorithms for rapid triage of acute myocardial infarction: an international collaborative meta-analysis.Ann Intern Med2022;175:101-13

[32]

Nilsson T,Lundager Forberg J,Ekelund U.Diagnostic accuracy of the HEART Pathway and EDACS-ADP when combined with a 0-hour/1-hour hs-cTnT protocol for assessment of acute chest pain patients.Emerg Med J2021;38:808-13

[33]

Clerico A,Zaninotto M.Head-to-head comparison of plasma cTnI concentration values measured with three high-sensitivity methods in a large Italian population of healthy volunteers and patients admitted to emergency department with acute coronary syndrome: a multi-center study.Clin Chim Acta2019;496:25-34

[34]

Chapman AR,Lee KK.Novel high-sensitivity cardiac troponin I assay in patients with suspected acute coronary syndrome.Heart2019;105:616-22 PMCID:PMC6580754

[35]

Reichlin T,Wildi K.Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay.CMAJ2015;187:E243-52 PMCID:PMC4435896

[36]

Rubini Gimenez M,Jaeger C.One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I.Am J Med2015;128:861-870.e4

[37]

Body R,McDowell G.Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay.J Am Coll Cardiol2011;58:1332-9

[38]

Reichlin T,Drexler B.One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T.Arch Intern Med2012;172:1211-8

[39]

Mokhtari A,Gilje P.A 1-h combination algorithm allows fast rule-out and rule-in of major adverse cardiac events.J Am Coll Cardiol2016;67:1531-40

[40]

Wereski R,Taggart C.Cardiac troponin thresholds and kinetics to differentiate myocardial injury and myocardial infarction.Circulation2021;144:528-38 PMCID:PMC8360674

[41]

Chew DP,Blyth A.A randomized trial of a 1-hour troponin T Protocol in suspected acute coronary syndromes: the rapid assessment of possible acute coronary syndrome in the emergency department with high-sensitivity troponin T study (RAPID-TnT).Circulation2019;140:1543-56

[42]

Sandoval Y,Daniels LB.Atherosclerotic cardiovascular disease risk stratification based on measurements of troponin and coronary artery calcium.J Am Coll Cardiol2020;76:357-70 PMCID:PMC7513421

[43]

Twerenbold R,Nestelberger T.Clinical use of high-sensitivity cardiac troponin in patients with suspected myocardial infarction.J Am Coll Cardiol2017;70:996-1012

[44]

Lopez-Ayala P,Koechlin L,Mueller C.Early rule-out strategies in the emergency department utilizing high-sensitivity cardiac troponin assays.Clin Chem2021;67:114-23

PDF

292

Accesses

0

Citation

Detail

Sections
Recommended

/